Clinical Trials in Spain / NCT06527521
Recruiting
Observational
Prevalence of Amyloidosis in Trauma Patients
NCT06527521 · tracked via the Priya Life Science Spain tracker
Condition(s) studied
Amyloidosis
Investigational drug(s) / intervention(s)
Traumatologic surgery
Traumatologic surgery: Patients undergoing trauma surgery
Study summary
This study aims to determine the frequency of amyloidosis among patients undergoing trauma surgery.
Eligibility
Inclusion Criteria:
* Men and women included in the waiting list for scheduled trauma surgery with at least one of the following criteria defined as red flags: Over 65 years old; Possible family history of amyloidosis, Cardiac pathology: aortic stenosis, presence of left ventricular hypertrophy defined as interventricular septal thickness \> 12mm measured by echocardiography, history of previous brady- or tachyarrhythmias including cardiac conduction blocks, history of syncope or presyncope, pro BNP \> 300 in previous blood tests; History of sensory peripheral neuropathy; History of nephropathy without etiological diagnosis; History of liver disease without a clear cause.
* Ability to cooperate in the necessary evaluations.
* Signed informed consent for inclusion in the study, either by the participant or their legal representative.
Exclusion Criteria:
\- Participants previously diagnosed with amyloidosis cannot be included in the study.
Primary outcome measure(s)
- Amyloidosis — One month
Proportion of patients undergoing scheduled orthopedic surgery who are diagnosed with amyloidosis.
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Consorci Sanitari Alt Penedes i Garraf-Hospital Sant Camil | Sant Pere de Ribes | Barcelona | Recruiting |
More Consorci Sanitari de l'Alt Penedès i Garraf trials in Spain
Acetic Acid 2% Solution for Skin Ulcers
Recruiting
Other trials for the same condition
Official registry record
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT06527521 on ClinicalTrials.gov ↗ ← All trials in Spain